Positive leadership communication can be an effective tool to reduce turnover and burnout among employees in the healthcare ...

Neffy, an intranasal formulation of epinephrine, is now available for emergency treatment of type I allergic reactions.

FDA drug alerts in pulmonology, including drug approvals/warnings, vaccine approvals, medical device recalls/updates, and ...

The cathepsin C (CatC) inhibitor BI 1291583 is associated with a decreased risk for an exacerbation in adults with bronchiectasis.

The U.S. government is offering another round of free COVID-19 tests, which will be available by the end of September.

Long COVID is common among veterans in the Airborne Hazards and Open Burn Pit Registry; however, the risk is not augmented by deployment exposures.

Multiple myeloma patients with COVID-19 have high rates of hospitalization, ICU admission, and death, according to researchers.

SGLT-2 inhibitors were associated with the lowest risk for incidental dementia relative to DPP-4 inhibitors and GLP-1RAs in type 2 diabetes.

Following COVID-19 vaccination, most patients with MS do not face an increased risk for relapse requiring corticosteroid therapy.

In lung transplantation, a short-term heparin-free ECMO anticoagulation strategy is safe and feasible perioperatively.

Reduced AMR proportions were noted for multiple pathogens from 2007 to 2019, but some previously declining trends have reversed course since the COVID-19 pandemic.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.